THE FIRST-OF-ITS-KIND NATIONWIDE EVENT
OFFICIAL TRANSCRIPT
star divider

Hello, I’m Mike Ward.

Welcome to the American Cannabis Summit: Countdown to Legalization.

Today, we’re going to make history.

During this exclusive event, you will be taken deep inside our nation’s most controversial – most misunderstood – and what’s quickly becoming – our most lucrative industry.

Mike, Danny, and Boehner on Set

We stand at the forefront of an unstoppable, economic revolution.

This is a new gold rush – a “Green Gold Rush,” and it’s just getting started.

star divider

No longer is tobacco America’s cash crop. 

With each day that passes, more farmers are becoming millionaires from growing cannabis.

Bold entrepreneurs are opening dispensaries from coast to coast.

The lines to get in are stretched around the corner.

And most of their new customers are senior citizens.

Cannabis tourism has become the latest craze in travel.

People are now skipping Napa Valley wine tours, choosing instead to embark on weed tours in Colorado and Oregon.

Doctors at leading institutes are now harnessing the plant’s medicinal power.

They believe miraculous treatments for chronic pain, insomnia, depression, and countless other conditions are within our reach.

Small Image if Device

And the most brilliant minds at universities like MIT and Stanford, are developing cutting-edge technologies to bring cannabis to the masses.

Imagine pushing a button on your cell phone and six cannabis plants begin to grow discretely in a small corner of your home.

This device automatically dispenses nutrients, optimizes the lighting, and even notifies you when it’s time to harvest.

You don’t have to imagine because that technology already exists.

It seems everywhere you look people are making a fortune from cannabis.

GA_08

Some invested in tiny marijuana stocks and watched as their holdings soared virtually overnight.

Others backed little-known startups long before they IPO’d.

Today, in the United States, cannabis is a $10.8 billion-dollar industry.

But what does the future hold?

star divider

Could America’s new cash crop become a $100 billion – maybe even $1 trillion industry?

You’re about to find out.

star divider

If you want to learn more about the cannabis industry…

If you’re seeking a way to break into this lucrative market…

Or if you’ve been biding your time, waiting for the right moment…

Then pay very close attention to everything you’re about to hear.

Because America’s green gold rush is just getting started.

As we speak, big investment firms and members of the Fortune 500 are building enormous war chests. 

They’re all preparing to push billions upon billions of dollars into this market.

And they could strike at any moment.

So right here – right now – you have a once-in-a-lifetime opportunity to beat them to the punch and stake your claim.

Your reward could be the kind of wealth that lasts for generations.

With me now are two leaders of America’s cannabis revolution.

Former Speaker of the House John Boehner...

And Danny Brody, an executive behind two of the largest cannabis IPOs in history – including the largest.

Gentlemen, thank you for joining us today.

SPEAKER JOHN BOEHNER: 

Happy to be working with you, Mike.

DANNY BRODY:

I’m excited to be on the team.

MIKE WARD:

We’ve got a lot of folks watching this now. 

This event is the first of its kind – ever.

It’s garnered quite a bit of buzz in the media.

We’re still tallying the final numbers, but we’re projecting that millions of people will be in attendance – watching from their homes and offices. 

Our inboxes have been flooded with questions.

Everyone wants to understand this industry. 

John, we’re a short walk from the Capitol Building – your old office.

You’ve been hearing from your friends that big changes are coming.

And frankly, you’re leading the charge – exerting your influence to push these changes through.

star divider

You’ve identified three events – they’re approaching fast – each will transform the cannabis industry forever.

star divider

You’re going to reveal them.

And more importantly, you are going to make a major announcement.

Outside this room, nobody has heard what you’re about to say.

But tomorrow, it could be on the front page of every newspaper from coast-to-coast.

SPEAKER JOHN BOEHNER:

We may turn a few heads.

MIKE WARD:

Danny, cannabis stocks have been popping up on exchanges for a few years now.

And what a wild ride it’s been.

One day, some are trading for pennies or fractions of a penny a share...

Then out of the blue, they shoot up thousands, even tens of thousands of percent...

Only to come crashing down to earth just as fast.

GA_10

All that volatility and risk has a lot of folks passing up these lucrative opportunities.

On the other hand, Danny, the cannabis firms you’ve taken public are now worth over $1.6 billion.

star divider

So we’re going to talk about how to separate the winners from the wannabes.

We’ve even identified three companies our viewers should consider targeting right now.

star divider

Plus, we have an entirely different opportunity to discuss – how to become a successful angel investor in privately held cannabis startups.

So let’s jump right in.

John, most folks are familiar with your story.

You were born in Cincinnati, Ohio. 

You grew up in a working-class family in a two-bedroom house with 11 brothers and sisters.

SPEAKER JOHN BOEHNER:

And we all shared one bathroom.

MIKE WARD:

You certainly didn’t let your humble beginnings hold you back.

John Holding the Gavel

While you were in office – you were one of the staunchest opponents of cannabis.

You said you were “unalterably opposed to legalization.

But then, in the spring of 2018, you shocked a lot of people on Capitol Hill.

You joined the board of Acreage Holdings – one of the largest cannabis firms in America.

star divider

So let’s address the elephant in the room.

star divider

Tell us, why did you have such a dramatic change of heart?

SPEAKER JOHN BOEHNER:

Headshot of John Boehner

Mike, that sound bite about being unalterably opposed to cannabis is almost a decade old.

Back then – like a lot of folks – I was getting faulty information.

One of the turning points for me was when I met this Navy SEAL.

Honorably served our country for 20 years.

He suffered horrible concussions, concussions, more concussions.

After he got out, he kept getting serious migraines.

Couldn’t see straight. Couldn’t think straight.

The VA prescribed him all these hardcore drugs.

He tells me, “I don’t want all these drugs.”

“I’ve got a wife and kids. I want to be a father.”

Refused to take his medication. He was just suffering.

Then he tries cannabis. The migraines vanished.

I started hearing a lot of stories of Vets using cannabis to treat their PTSD, depression, chronic pain – it was helping them.

So I started researching the industry.

Did you know cannabis was a major part of early America?

Our founding fathers – George Washington and Thomas Jefferson both grew it on their farms.

Take a look at this, Mike.

You’ll get a kick out of it.

This is a $10 bill from 1914.

Front of 10 Dollar Bill

You have President Andrew Jackson on the front.

Back then he was on our $10 bills.

You flip this over and what do you see?

Back of 10 Dollar Bill

Those are American farmers harvesting cannabis.

star divider

Cannabis was such an important cash crop –
it made it onto our money.

star divider

Then you start digging into the medical uses and it’s astounding.

Back in 1909, a leading American Medical Journal recognized cannabis as a potential cure for asthma and tuberculosis.”

"The plant can be used in the cure of asthma, tuberculosis, etc."
-James Love
Pacific Drug Review (1909)

You can go back even farther – 4,000 years ago – biblical times – that’s when people started using cannabis as medicine.

So I realized I was wrong.

And let me tell you, I’ve been having more and more meetings with my friends and colleagues on the Hill about this.

Some of the most conservative politicians around.

Their views are evolving on cannabis too.

C_26

Just like the American people.

star divider

This is a phenomenon. Cannabis is here to stay. And this industry is only getting bigger.

star divider

When I was presented with the opportunity to join Acreage Holdings, I jumped at it.

We’re a fully integrated cannabis firm with dispensaries, cultivation, and processing operations in 14 states.

With three deals pending to take us to 17 states.

We’re a major player.

And we’re only getting bigger.

MIKE WARD:

You’re all in on cannabis.

SPEAKER JOHN BOEHNER:

Yes, I’m all in.

star divider

This is the time to go all-in on cannabis.

star divider

MIKE WARD:

Danny, you were an architect behind two of the largest cannabis IPOs in history.

The first, Emblem Corp., you took public in December of 2016.

They’re a large producer of medical-grade cannabis.

And then in May of 2018, you took The Green Organic Dutchman public.

I_03

It was immediately hailed as the largest cannabis IPO ever.

Now your team is using this capital to build cultivation facilities in Ontario, Quebec, and Jamaica.

Today, these companies are worth about $1.6 billion.

And it’s worth mentioning, they are both Canadian firms.

Canada just put an end to their prohibition.

C_27a Headshot of Danny Brody

Like here in America, we’ve already seen a bunch of cannabis firms shoot up on their stock market.

DANNY BRODY:

Right, which is really incredible when you think about it.

Canada – the entire country – has fewer people living in it – than the state of California.

And get this – the rosiest projections have the country’s cannabis market hitting $9 billion by 2025.

star divider

In the United States, this industry is already north of $10 billion annually. And we’re still at the very earliest stages of this economic boom.

star divider

The U.S. is where all of the action is going to be for a while.

MIKE WARD:

Danny, things have been moving very fast.

New developments, rumors, and deals are being announced around the clock.

Why don’t you quickly take our viewers through the current state of the cannabis industry in America?

DANNY BRODY:

Sure thing.

Let’s put up the map.

GA_16a

You’ll see we have 31 states where medical cannabis is legal.

We can also add Guam and Puerto Rico.

Okay, can we change the map?

GA_16

Now we have only nine states highlighted – including some big ones, like California and Colorado.

This is where both medical and recreational cannabis is legal.

So you can see, we’ve got a long way to go, to reach full legalization.

That hasn’t stopped this industry from experiencing explosive growth.

C_28

Revenue has quadrupled between 2014 and today, hitting $10.82 billion.

Let’s talk about jobs...

Right now, cannabis businesses employ 200,000 Americans.

That trend is not going to slow down either.

star divider

Forbes is reporting that, by 2020, we could have more cannabis jobs in the U.S. than manufacturing jobs.

star divider

SPEAKER JOHN BOEHNER:

Danny hit the nail on the head.

When I’m talking to politicians, cannabis jobs are a major selling point.

But so is the tax revenue.

Colorado, perfect example.

Since 2014, they’ve collected in the neighborhood of $815 million in tax revenue from cannabis.

That’s not $815 million in sales. 

They’re ringing up billions there.

That’s $815 million in just tax revenue.

Colorado poured that money into infrastructure projects, plugging holes in budgets, healthcare – heck, $21 million was handed to law enforcement.

I_04

The police are using cannabis tax dollars to keep the streets safe.

And the biggest chunk of this cash, $200 million, has gone toward building new schools.

Out in Deer Trail, Colorado, there was an elementary school that was falling apart.

Thanks to all of those cannabis tax dollars, Deer Trail got a new elementary school.

MIKE WARD:

If cannabis is already a $10 billion industry in America – it’s creating all of these jobs and tax revenue – yet, we’re still at the very beginning of this boom.

star divider

How Big Could This Really Get?

star divider

SPEAKER JOHN BOEHNER:

Look – this rapid growth is happening while cannabis is still quasi-legal.

The federal government is holding the industry back in a serious way.

But even if nothing changes, our guys are projecting it will reach $50 billion within five years.

MIKE WARD:

What if something big does change?

star divider

What if the federal government legalizes cannabis? 

star divider

SPEAKER JOHN BOEHNER:

It’s not a matter of “if.” It’s a matter of "when."

This is inevitable.

Voters want it.

Economic benefits are too big to ignore.

I have to choose my words carefully.

What I’m hearing behind closed doors is sensitive.

star divider

Let me just say, I have a strong suspicion we won’t be waiting five years to see the federal government legalize cannabis.

star divider

When that happens, whenever that happens, our guys are saying the industry will double, practically overnight.

MIKE WARD:

$100 billion just in the United States.

SPEAKER JOHN BOEHNER:

$100 billion.

Like I said, that’s practically overnight.

Long term, the numbers are off the charts.

Those 200,000 jobs Danny just mentioned? 

With full legalization – that could hit 1.1 million jobs.

And $100 billion in revenue? We might just blow past that.

DANNY BRODY:

star divider

Globally, this could become a $1 trillion industry.

star divider

Simply because it affects so many others.

Food and agribusiness is a $5 trillion industry.

Alcohol, $1.3 trillion.

The pharmaceutical industry is good for another $1.1 trillion.

When we get full legalization, you’re going to see the floodgates open in these industries and so many more.

MIKE WARD:

You both believe the federal government is going to end this prohibition – and legalize cannabis.

That hasn’t happened yet.

Let’s talk about the ongoing challenges this presents to the industry.

SPEAKER JOHN BOEHNER:

There are three big ones.

Starting with cannabis being classified as a Schedule 1 drug.

But let me push back on calling these challenges.

I think these are enormous opportunities.

star divider

You have the ability to get in on the ground floor of the biggest economic phenomenon of our lifetime, before it really takes off.

star divider

MIKE WARD:

For folks who aren’t familiar with the term, when you say cannabis is a Schedule 1 drug – what exactly does that mean?

SPEAKER JOHN BOEHNER:    

The FDA slaps a label on every drug from a bottle of aspirin – to the illegal stuff.

They’re each classified somewhere between Schedule 1 and Schedule 5.

Schedule 1 is for the most dangerous and addictive drugs – five the safest.

GA_17

They have cannabis as a Schedule 1 drug right next to heroin, LSD, peyote, and ecstasy.

Jump down to Schedule 2 – and you’ll find cocaine and meth along with prescription drugs like Adderall and Vicodin.

DANNY BRODY:

Isn’t that absurd?

I don’t care how you feel about cannabis, nobody in their right mind thinks it’s more dangerous than cocaine or meth.

I mean – anabolic steroids are a Schedule 3.

Yet, somehow cannabis is grouped with heroin and ecstasy. 

SPEAKER JOHN BOEHNER:

There is no rational explanation for this.

According to the DEA, Schedule 1 drugs are highly addictive and have no medical benefits.

star divider

Cannabis is NOT highly addictive.

There have been more than 23,000 scientific papers released on its potential medical applications.

star divider

Alzheimer’s, cancer, epilepsy, post-traumatic stress disorder, autoimmune diseases… the list goes on and on.

Our guys estimate that about 80% of all cannabis use is medical.

Every single day since I’ve become involved in this industry, I’ve had people tell me it is helping them.

I was just in the Fort Myers Airport and this older gentleman stops me and says:

“John I wanna thank you for your position on this issue. I’m 85-years old. I’ve got really bad arthritis. And if it weren't for cannabis, I couldn't function."

MIKE WARD:

People spend a lot of money treating their arthritis.

star divider

Chronic pain is a $77 billion industry.

Cannabis only needs to capture a tiny fraction of that market to have an enormous impact.

star divider

Same goes for sleep-related issues like insomnia.

We’ve got somewhere between 50-70 million Americans dealing with this.

SPEAKER JOHN BOEHNER:

If you walk into your doctor’s office and say, “Hey doc, I can’t sleep,” what will your doctor prescribe you?

MIKE WARD:

Probably, Ambien.

Maybe Lunesta?

SPEAKER JOHN BOEHNER:

Exactly.

Those drugs – Ambien especially – can have pretty nasty side effects.

Some folks will take them, go on a joyride, wake up in a cornfield in the middle of nowhere, and they can’t remember a damn thing. 

DANNY BRODY:

star divider

Pharmaceutical companies are on track
to make about $102 billion a year selling dangerous sleep drugs.

That presents a $102 billion opportunity for cannabis.

star divider

Treating Crohn’s disease is also worth paying attention to.

There was a study in Israel where 90% of patients saw significant improvement after using cannabis.

Nearly half went into complete remission.

We can add another $7.6 billion opportunity for cannabis therapies right there.

MIKE WARD:

Another place cannabis could make a difference is with epilepsy, childhood epilepsy in particular.

star divider

Go on YouTube and you’ll see parents posting before and after videos of their kids – kids who used to be struck by 50 seizures a day – now they’re experiencing zero.

star divider

Check this out.

Here’s a brain scan of a little girl who was forced to live with non-stop epileptic seizures.

This is before she underwent cannabis therapy:

Before Therapy Image

Here’s what it looked like after:

After Therapy Image

It’s amazing. 

DANNY BRODY:

Scientists have engineered these treatments, so they don’t contain THC. 

THC is what makes someone feel high from cannabis.

And the FDA has already approved one cannabis treatment for epilepsy.

In fact, they even made a special exception and dropped this specific drug down to a Schedule 5. So it’s right next to Robitussin.

The firm behind this drug – GW Pharmaceuticals – they’ve shot up over 1,800%.

C_32

They’re worth about $4 billion.

SPEAKER JOHN BOEHNER:

Ya know, epilepsy is very expensive to treat. 

People were spending $10.4 billion a year.

But there is some good news.

Recent studies suggest costs are going to be cut in half – down to $5 billion.

Due, in large part, to the potential of cannabis treatments.

This could lessen the financial burden for those with epilepsy, while still creating a $5 billion revenue stream.

That’s a win-win in my book.

And there are many pharmaceutical companies working on even more promising treatments for countless conditions.

All using cannabis.

MIKE WARD:

star divider

So how is cannabis being a Schedule 1 Drug holding back this progress? Bureaucratic red tape?

star divider

SPEAKER JOHN BOEHNER:

Exactly, Mike.

Here’s how screwed up this is.

A doctor in California wanted to study cannabis as a treatment for veterans with PTSD.

It took her seven years to navigate through this regulatory mess to receive approval.

Next, she had to purchase cannabis from what was, until recently, the only place the federal government allowed. A lab at the University of Mississippi.

20 months later, they sent it to her and it was full of mold.

MIKE WARD:

Almost nine years to get a study off the ground?

This is not a system that is conducive to getting results.

SPEAKER JOHN BOEHNER:

Fortunately, there is mounting pressure to fix this issue.

Obviously, from the American people.

But many in the government are doing their part as well.

“Advancing sound scientific research to investigate ingredients derived from cannabis can lead to important therapies.”
- Scott Gottlieb, M.D.
Commissioner, U.S. Food and Drug Administration

The head of the FDA believes scientific research into cannabis could lead to the discovery of important medical therapies.

“The FDA will continue to support rigorous scientific research on potential medical treatments using cannabis.”
- Scott Gottlieb, M.D.
Commissioner, U.S. Food and Drug Administration

His gave his team the greenlight to continue exploring these breakthroughs.

But the big move needs to come from the DEA.

star divider

They drop cannabis to a Schedule 2 or 3 drug – you will quickly see a boatload of money flood into research projects.

star divider

From there, new treatments and therapies will follow.

That’s when the stocks of a bunch of small pharmaceutical companies could go on a run. 

They won’t be the household names either.

If you move now, you’re going to be really happy a little bit down the road.

So I look at this as an opportunity, not a challenge.

The same goes for the extreme banking restrictions that have been placed on the industry.

That’s the second major roadblock.

Right now, cannabis companies are cut off from using regular banks – and securing traditional financing through those banks.

For the most part, they’re forced to rely on local credit unions.

There is over $1 billion in cannabis cash sitting in those vaults.

star divider

Something has to be done with Cannabis Banking. And something WILL get done soon.

star divider

MIKE WARD:

You sound pretty confident about that.

SPEAKER JOHN BOEHNER:

I used to count votes.

I know where the votes are.

The votes will be there when the time is right.

MIKE WARD:

You’re friends with President Trump. How does he really feel about legalizing cannabis?

SPEAKER JOHN BOEHNER:

If I tell you about our private conversations, I won’t have any more of them with the president.

What I’m willing to say is…

star divider

After I came out in favor of cannabis, President Trump said, "I agree with Boehner. I think he's right."

star divider

MIKE WARD:

Trump’s Treasury Secretary – Steve Mnuchin – seems to be voicing support for legalization.

He’s quoted as saying the cannabis industry’s banking problem is on the top of his list and his team is working on it now.

DANNY BRODY:

While Secretary Mnuchin is working on this, the average investor has an opportunity to strike.

And they should.

With traditional investments, only 17.5% of the money comes from little fish like you and me, Mike.

C_33

The other 82.5% is from the big players – the major investment firms, hedge funds, pension funds, and established corporations.

Banking restrictions are preventing almost all of those investment firms and funds from diving headfirst into cannabis.

SPEAKER JOHN BOEHNER:

They’re dying to get in.

I’m helping some of these bigger fish get ready to invest.

star divider

There’s hundreds of billions of dollars sitting on the sidelines.

star divider

DANNY BRODY:

That’s exactly what happened in Canada.

They had been talking about full legalization for years. 

It was as close to a sure-fire thing as it gets.

star divider

So the heavy hitters – the Vanguards, Morgan Stanley’s, BlackRock’s – they started making the trip up to Canada with their big bags of cash in hand.

They knocked on the doors of these tiny cannabis firms and suddenly, they weren’t so tiny anymore.

star divider

Take Aphria.

By the fourth quarter of 2016, it was clear they had a bright future.

Aphria had a market cap of $313 million – that’s Canadian dollars.

Then the major institutional firms came knocking.

Vanguard, Credit Suisse, RBC, BlackRock all locked up their stakes. 

Aphria’s stock took off like a rocket.

About a year later, it had shot up as much as 659%.

C_34

Their market cap has now reached $4.3 billion.

You’ll find a similar trajectory with Aurora Cannabis.

During the third quarter of 2017, they had a market cap of about $760 million.

Then they caught the attention of the major institutional firms.

Horizons Investment Management struck first. 

After that, we had Goldman Sachs, Deutsche Bank, and UBS among others, joining them.

Aurora’s stock went on a tear, rising as high as 641%.

C_34

Today, you’re looking at a company with a market cap of $11.7 billion.

One more – Canopy Growth. 

Right now, they are one of the largest cannabis firms on the planet. 

They do business in, I believe, 11 countries across five continents.

They grow cannabis and process it into oils, soft gel capsules, just about anything you can imagine.

Back in Q1 of 2015, they were barely a blip on the radar.

Their market cap was around $90 million Canadian.

What we’d call a micro-cap stock. Really tiny. Really volatile. 

Micro caps have more risk, but if you find the right one, it can take off.

This time it was BlackRock who got things moving.

Not long after, Goldman Sachs, Morgan Stanley, State Street, and others jumped on the bandwagon.

Since they made their moves, Canopy Growth has hit peak gains of 3,813%.

C_36

They are now worth $14.4 billion.

MIKE WARD:

Okay, you talked about cannabis being a Schedule 1 drug and the banking restrictions on the industry – let’s examine that third challenge that we can flip into an opportunity.

SPEAKER JOHN BOEHNER:

This comes down to yet another boondoggle at the IRS.

There is a specific code that needs to be reformed – IRS Code 280E.

In a nutshell, if you have a business that directly touches cannabis – like dispensaries – you can’t deduct normal expenses.

Employee salaries, rent, utilities, advertising – that kind of stuff.

I’m telling you, some of the most brilliant minds in accounting are now focused on the cannabis industry – they’re creating these complex strategies for working around IRS Code 280E.

In reality, they won’t need to do that much longer. 

This is the low-hanging fruit. The easiest challenge to solve.

My former House colleagues are already working on this.

star divider

Once we change IRS CODE 280E, every company in the cannabis industry instantly gets a massive tax cut.

star divider

This could singlehandedly, double or triple their profits.

MIKE WARD:

Naturally, that would lead to rapid growth in the industry.  

I can easily see that adding tens of billions of dollars by itself.

How long until you think that law will be changed?

SPEAKER JOHN BOEHNER:

Not long.

I believe the timeline will be measured in months more than years.

There’s a group in Congress working right now to fix it. 

It’ll get fixed. 

Everybody wants it.

MIKE WARD:

Gentlemen, we’ve got a big announcement to make.

Everybody is going to want to hear this.

In a few moments, we’re also going to examine the three cannabis investment opportunities our viewers should consider immediately.

But first, let’s discuss what’s next for this industry.

It’s growing faster than any other in America.

What we know about all industries – Harvard did a great study about this – they all go through four major stages.

It happened with railroads, energy, telecom, automotive, internet, you name it.

GA_18

The first phase is a free-for-all.

There are tons of startups and small firms. New players are constantly entering the market. 

Nobody has a giant market share. No clear winners yet.

Phase 2 is where we see massive consolidation.

Smaller companies start merging.

Bigger companies acquire smaller ones. 

Phase 3 is when the mega-deals happen. 

The big guys start merging with each other.

We’ve seen plenty of these deals eclipse $100 billion.

Then Phase 4 is where the action slows down.

You have just a handful of big players in an industry.

This is the blue-chip stock phase. 

John, where do you think cannabis falls on this timeline?

SPEAKER JOHN BOEHNER:

star divider

We’re in a sweet spot right now.

star divider

Cannabis is nearing the end of Phase 1.

Here’s what gets me really excited.

We’re starting to see those red blinking lights, signaling this industry is about to jump into Phase 2 with a bang.

Rapid consolidation could lead to rapid profits for those who strike right now.

The writing is on the wall.

Scott’s Miracle-Gro – the boring fertilizer company – they were one of the first movers.

Their CEO declared that cannabis was “the biggest thing he’s ever seen.”

Initially, he committed to investing $500 million in the sector.

But then he starts buying cannabis companies and he can’t stop.

Hydroponics and lighting companies, companies that sell soil to cannabis farmers.

He’s already cut checks totaling $705 million. 

Scott’s Miracle-Gro isn’t the only household name eyeing the cannabis market.

Johnson & Johnson has linked up with two small firms.

Coca-Cola is a big as well. 

They’re talking about making cannabis-infused beverages.

I was on the board of a major tobacco company – Reynolds.

star divider

You think big tobacco is staying on the sidelines? I’ve talked to these guys. They aren’t going to sit this one out.

star divider

And they have the dollars to acquire whoever they want.

We’re just beginning to see some action in this space.

Imperial Brands – makers of Kool and Winston Cigarettes – they invested in a medical marijuana research firm in the U.K.

DANNY BRODY:

We can’t forget the alcohol companies.

On August 1, Molson Coors announced they were partnering with Hexo Corp. to create cannabis-infused beverages.

Almost immediately, Hexo’s stock jumped as much as 124%.

About two weeks after the ink dried on that deal, Constellation Brands pulled off one of their own.

Constellation owns Corona.

They invested $5 billion in Canopy Growth.

Canopy’s stock jumped as much as 133% after that deal.

Not bad.

But remember, if you were one of their early investors, you’d be looking at peak gains of 3,813%.

C_36

With Hexo, their early investors could’ve been up 670%.

C_37

MIKE WARD:

star divider

It’s been the worst-kept secret that some of these household names were chomping at the bit to get into cannabis.

star divider

What’s intriguing though is watching the larger cannabis firms begin to push their weight around to scoop up smaller competitors.

DANNY BRODY:

Aphria – case-in-point.

I told you how their stock went up 659% after they began cashing checks from institutional firms.

But go back even further – to earlier in their Phase 1 days – shares have risen as much as 4,720%.

C_39

All of this growth and investment capital left them flush with cash.

So they spent $425 million to acquire Nuuvera.

Nuuvera’s appeal was pretty obvious. 

They were a Canadian firm that received approval to export cannabis to countries where it was legal.

If you were an early investor in Nuuvera and were holding those shares when Aphria purchased them, you could’ve made 976%.

SPEAKER JOHN BOEHNER:

Mike, the moral of the story is, cannabis is about to enter its second phase.

But it’s not there yet.

We’re still in Phase 1, but barely.

That means…

You can still stake your claim in some of the firms for fractions of what they could be worth weeks or months from now.

star divider

The next generation of billion-dollar cannabis companies are ripe for the picking.

star divider

You just have to make smart moves.

Don’t go blindly investing in this sector, because it’s exciting and you don’t want to miss the boat.

The boat hasn’t left the dock yet.

MIKE WARD:

That’s exactly what our big announcement is about.

John, like you, my own views on cannabis have evolved.

You know this already, but I’ll explain for the folks at home.

As the publisher of Money Morning, I’m responsible for making sure we provide safe and profitable financial advice for our 3.6 million daily readers.

My analysts and researchers have been closely tracking the cannabis sector for years.

Initially, we decided that pot stocks were just too dangerous to recommend.

It was the Wild, Wild West.

A bunch of fly-by-night companies with suspect financials.

Some of these stocks would just explode and then come crashing down.

No rhyme or reason to it.

I remember looking at a tiny company called Praetorian Property.

Their business model consisted of buying rundown real estate in bad neighborhoods and then leasing it out to cannabis firms.

Praetorian goes public in 2011.

2012, the stock starts moving a little bit.

Then in 2014, it mysteriously just shoots up.

This stock jumped 135,000%.

C_41

Almost right after – it collapses.

C_41

We went digging and digging – couldn’t find any real legitimate reason for the rise or fall.

We chalked it up to some outside group pumping and dumping the stock.

There were a lot of suspicious moves like that.

By 2016 though, we noticed the industry was getting its act together.

My team came to me and said…

“Look we have the November elections coming up. We’ve noticed that certain cannabis stocks are susceptible to big jumps, whenever states pass new laws.”

They had already examined 64 companies that had shot up over 1,000%.

11 surged past 10,000%...

Five over 25,000%...

And three stocks had jumped at least 50,000%!

We determined that this fast movement was due, almost entirely, to new cannabis laws being passed.

So in November of 2016 – we had Massachusetts, Maine, Nevada, and California voting to legalize recreational cannabis.

We had Arkansas, North Dakota, Montana, and Florida looking to pass new medical marijuana laws.

I knew this had the potential to be an incredible opportunity.

So I instructed my team to release all of our research on our top 30 cannabis stocks.

When the dust had settled from the 2016 election, those states approved their new laws.

And in the months that followed all 30 stocks we recommended were up.

In fact, 17 of them had reached triple digits.

Almost immediately after we released those recommendations, I started getting flooded with letters thanking me.

I remember reading one from a Korean War Vet. 

He was 83 years old and called this opportunity a goldmine.

“I made $5,000 my first month. The next day another $1,253.  The day after another $1,385. And the day after that another $1,727. I still can’t believe it. This keeps getting better.”
- Jimmy Wasserman

But he wasn’t alone.

We had other folks who were up $15,000 or more in a matter of days.

“In 3 days, I’ve made $15,000!”
- Susan Gerry
“I’m up $17,000 in 11 days!”
- Chuck Ardeen
“+$20,000 after three weeks!”
- Kristin Benjamin

Tens of thousands of dollars in a few weeks.

“I’m completely new to investing. And thanks to you, I’m up $25,000.”
- Luke Delando
“This is the greatest investment I’ve ever made. My profit after 2.5 weeks was $39,593!”
- Suzanne Wilshire

Besides being new to investing in cannabis stocks, some of these folks had barely invested in anything at all, ever.

And yet they still saw the potential of this industry.

Another reader perfectly summed up this opportunity.

“In under a month, I made $44,958. I’m going to be a marijuana millionaire!”
- Rick Hoshkins

John, Danny – seeing the response from these people – how successful they were from cannabis investing – it changed my mind.

SPEAKER JOHN BOEHNER:

You saw the light.

MIKE WARD:

Yes, but I also saw what happened after.

The charlatans started coming out of the woodwork.

We started seeing sketchy companies promising magical “Pot Stock Blueprints.”

They were telling folks they could turn $50 into $1 million.

DANNY BRODY:

I’ve seen ads just like that.

Guys that are probably working out of their mom’s basements, peddling bad information to make a quick buck.

Just preying on people’s excitement.

MIKE WARD:

That’s why I approached both of you.

There are millions of Americans hungry for credible information on cannabis investing.

Straight talk on the risks and opportunities. 

So we laid out a pretty bold plan.

Let’s get all of the experts in the cannabis industry on the same team.

We’ll create a united front.

We’ll use our combined expertise to bring our members the absolute best research and the most lucrative investment opportunities in the cannabis industry. 

star divider

Today, we are officially launching
The National Institute for Cannabis Investors.

star divider

John, there’s no one in the cannabis industry who’s more connected inside Washington.

People would pay millions of dollars to be a fly on the wall at some of the meetings you’re involved in now.

So having you as part of the Institute is priceless.

SPEAKER JOHN BOEHNER:

I’m happy to be working with you.

As I said, I’m all in on cannabis.

MIKE WARD:

Danny, having taken two cannabis firms public, including the largest cannabis IPO in history, your insights on private deals and IPOs is unmatched.

DANNY BRODY:

Glad I can contribute.

We’re going to do some big things together.

MIKE WARD:

With you guys on board we invested millions of dollars into expanding our team of analysts and researchers.

Then we went out and established our founding board.

Headshot John Vardaman Headshot Michael Robinson Headshot Avtar Dhillon Headshot Dr. Michael Dor

John Vardaman is on it.

John was a senior lawyer in the Department of Justice for Presidents Bush and Obama.

In 2014, he drafted the Cole Memo that said the federal government won’t go after states that legalize cannabis.

Michael Robinson’s specialty is venture capital and cannabis technology investing.

We have Avtar Dhillon.

Avtar is the first chairman of the Cannabis Canada Association.

He was also the former CEO of Inovio Pharmaceuticals.

Dr. Michael Dor has signed on as well.

Dr. Dor graduated from both Tel Aviv University and Harvard.

And today he’s the senior advisor on cannabis research for the Israeli Ministry of Health.

SPEAKER JOHN BOEHNER:

That’s a big deal.

We didn’t touch on Israel, but they’re an important part of the cannabis industry.

With all the restrictions on research over here, some of the best work is being done in Israel.

MIKE WARD:

Exactly.

And these are just a few of the many people we’ve added to the board.

Now we’re inviting the folks watching this at home to join our team as founding members.

Nobody has ever done anything like this before.

star divider

We are going to be THE source for cannabis investing.

star divider

I’m sure our viewers have a lot of questions.

Let’s answer them.

Danny, let’s say I’m someone who is interested in joining this venture, what can I expect?

DANNY BRODY:

We’re going to be primarily targeting four main areas of the cannabis industry.

  1. Breakthrough Treatments – so the companies developing pharmaceutical-grade and natural health therapies and drugs.
  2. Billion-dollar brands – these are the tiny firms that have the potential to, the name says it all, become brands that are worth billions of dollars. I’ve helped launched them myself. A lot of folks on the board have too.
  3. We’re also going to focus on Cannabis Tech
  4. And finally, Angel Investing.

MIKE WARD:

We know members are going to want to get started right away so we’ve prepared four special reports.

One for each of these areas.

We’ll be sending them out in just a few minutes when this broadcast ends.

Let’s talk about the firm we have lined up for our Breakthrough Treatment play.

SPEAKER JOHN BOEHNER:

We believe we’ve got somebody who is ready to capture a big piece of the $1.1 trillion pharmaceutical industry.

Cannabis is just starting to break into this market.

The FDA approving GW Pharmaceutical’s epilepsy treatment was only a sign of things to come.

Cannabis drugs for epilepsy could be a $5 billion opportunity.

That’s why GW Pharmaceutical’s stock is up as much as 1,830%.

C_42

We believe the company we’re recommending has an even better treatment.

And it’s not just for epilepsy. 

I’ll explain, but pardon me if I don’t get too technical.

Basically, a cannabis plant has two active parts.

There’s THC.

Then there’s CBD. 

That’s the part showing the most medical promise right now.

The guys we’re looking at were one of the first to prove CBD could be used to stop epileptic seizures.

Now, if you’re taking cannabis purely for medical reasons, you are going to want something with as little THC as possible – but the purest dose of CBD you can get. 

GW Pharmaceutical’s drug is called Epidiolex.

It has a fair amount of THC in it. 1,500 parts per million.

If I’m the parent of a child with epilepsy, I’m giving it a lot of thought before I let my son or daughter take a drug with that much THC in it.

The firm we’ve vetted has a therapy with only 13 parts THC per million.

That means their CBD is purer. 

It’s also much cheaper.

GW Pharmaceutical’s drug costs $2,708 a month.

Our firm, only $99 a month.

DANNY BRODY:

Another problem with GW’s drug is, that FDA approval itself.

It’s only approved for epilepsy.

A $5 billion market is not bad.

But if you have the ability to treat a lot of conditions, you’re going to be in the driver’s seat. 

The firm we’re targeting has created:

And here’s an enormous competitive advantage.

You need a prescription for GW’s drug.

All of our firm’s products are available over the counter.

No prescription necessary.

And they have the potential to treat many conditions.

The biggest opportunity being chronic pain.

MIKE WARD:

That’s what stood out to me, Danny

star divider

If you can safely treat pain –
you can also fight the opioid epidemic.

star divider

We lose far too many people to opioid overdoses.

Much more than any drug.

C_43 Drugs Involved in Overdose chart

Nobody has ever overdosed on cannabis. 

That’s probably a reason Dr. Sanjay Gupta went out and talked to the founders of the company we’re recommending.

star divider

He said if he had to design a drug from scratch to fight the opioid epidemic, “it would look a lot like cannabis.”

star divider

SPEAKER JOHN BOEHNER:

We know from a list of studies that opioid overdoses have fallen in states where cannabis has been legalized.

Politicians are quickly opening their eyes about this.

Last summer, the Governor of Illinois made it legal for doctors to prescribe cannabis to patients instead of prescription painkillers.

This will put the $77.1 billion chronic pain market up for grabs over the next few years.

DANNY BRODY:

Add sleep problems to the list too.

That’s another $10 billion market by 2020.

You start thinking about all of the possible medical applications and your head will spin.

Big picture…

star divider

Cannabis, more specifically CBD-based treatments, are one of the biggest opportunities in the industry.

star divider

The market is set to grow 3,667% over the next five years.

MIKE WARD:

And the firm we’ve identified is set to capture the lion’s share of this market.

I think we should stress again that they can sell their products over-the-counter, without a prescription.

They’re already on the shelves at 2,700 retail stores across the country.

And year-over-year, their revenue has jumped 172%. 

But there is a great deal of room for growth still.

We’ve learned they’ve been talking to Target.

DANNY BRODY:

Yes, we have.

If they work out a distribution deal, that could put them in 1,839 more stores.

Think about Whole Foods. They have 490 stores.

Or Krogers – there’s another 2,780.

Safeway, Publix, all these grocery stores could stock these products on their shelves in all 50 states.

Do on the 50 States

The upside here is really big.

They just had their IPO a couple months ago.

We’ve already seen a handful of unusual – really exceptional returns from cannabis firms working on medical therapies.

In our opinion, we’ve got the best medical CBD play out there today.

MIKE WARD:

Everything is in this Special Report – we’re calling it: Prescription-Free CBD:
The Firm Set to Disrupt the $1.1 Trillion Pharmaceutical Industry 

Prescription Free CBD and Innorator Report

We’ve also identified our top cannabis tech opportunity. This company has a simple solution for a big problem.

It’s in our second Special Report – The Innovator.

What should our viewers know about this company?

SPEAKER JOHN BOEHNER:

I know I speak for a lot of folks when I say I like investing in things I understand.

In the tech sector, we’re bombarded with companies building robots with artificial intelligence, or rocket ships to mars, or chips that will, supposedly, be implanted in our bodies. 

Things that sound like they’re from a sci-fi movie.

But time-and-time again what makes money in tech is a basic proposition: “You’ve got a big problem – I’ve got a simple solution for it.”

I_Pill Bottle

We’re all familiar with this.

Just a regular old, prescription pill bottle.

Some folks making these bottles refused to work with cannabis companies.

But you walk into a dispensary and every product you buy is required to come in child-resistant packaging.

This young man, just out of college, says, “I can do that.”

Some years back, he invents a child-resistant top for a bottle.

He goes around to all the companies in California and Colorado that are selling cannabis and tells them, “Hey, I hear you need this.”

And he can’t make these bottles fast enough. Everybody is buying them. 

They have a wide assortment of products.

Pre-roll containers. Child-proof, pop-top bottles. You name it.

MIKE WARD:

This company is taking off.

They have sold over a billion units.

And to your point, the cannabis industry had a big problem – they needed safe containers for their products.

This company had a simple solution – they invented those containers.

You can make your shareholders very happy if you deliver on that very basic proposition – big problem, simple solution.

A ways back we saw this with a company called GrowGeneration.

They solved a simple problem.

In most places, growing season for cannabis isn’t year-round.

But the demand for cannabis is.

That’s why farmers set up indoor operations in greenhouses.

That requires a lot of space if you want to grow a serious amount of cannabis the traditional way.

Instead, farmers turned to a method called hydroponics.

It allows you to grow cannabis without soil.

It requires significantly less space.

GrowGeneration sells hydroponics technology.

C_44

With soaring demand in the industry, their stock has jumped as much as 563%.

DANNY BRODY:

Cannabix Technologies also invented a simple solution for a big problem.

If someone is driving under the influence of alcohol and a cop pulls them over, they’re going to get a breathalyzer test.

What happens if the cop suspects they’re driving under the influence of cannabis?

Cannabix Technologies developed a breathalyzer that can detect THC on your breath.

C_45

Their stock has gone up as much as 5,826%.

MIKE WARD:

So what’s the potential upside for our target?

DANNY BRODY:

It’s bigger than the companies I just mentioned, that’s for sure.

This is imminent. Cannabis is about to enter into a phase of massive consolidation.

During this consolidation, we expect this firm to be acquiring companies, not being acquired.

In 2014, they sold $1.71 million worth of product.

This year, they’re at $51 million.

That’s 30X growth in a fairly short amount of time.

It proves they have traction.

Yet, considering this will be a multibillion-dollar market, they’re still tiny.

Nonetheless, they’ve been strategically buying up their smaller competitors.

And they’ve moved beyond offering just child-proof bottles.

They have all kinds of packaging and solvents for processing cannabis.

And they’ve got a lot of clients.

They count 5,000 cannabis companies as customers.

And seizing on that opportunity, they bought a digital creative agency that helps their clients with branding.

That’s another growing revenue stream for them.

They check off a lot of boxes for me.

MIKE WARD:

We’ve got the full story on this company in our second Special Report.

Now let’s talk about our third.

WYG_03

It reveals our top, Billion-Dollar Brand play.

We’re calling this report: Cannabis’s First Household Name.

John, what’s your take on it?

SPEAKER JOHN BOEHNER:

At Acreage, we’re betting brands are the future of cannabis. 

So what makes a great brand?

Molson Coors Brewing is a $14 billion company.

Not because they just sell beer.

No, they sell brands of beer. 

Brands people like. 

Miller, Coors, and Molson.

Diageo is the world’s biggest liquor company. They’re worth $84 billion.

You go out on the street and ask 10 people if they’ve ever heard of them, I’ll guess one, maybe two have.

Ask them if they’ve heard of Johnnie Walker, Smirnoff, and Captain Morgan, you’ll go 10 for 10 – everybody knows those brands.

Anheuser-Busch InBev is worth $178 billion.

They’ve got Budweiser and Modelo.

MIKE WARD:

What leads you to believe the company in this Special Report will become a billion-dollar brand?

DANNY BRODY:

star divider

We believe we’ve identified the next big brand in cannabis.

star divider

They have a lot going for them.

First, obviously you need a good product.

They have developed a line of high-quality cannabis oils.

This stuff is very potent, too. 

It’s six times stronger than smoking the plant.

A couple of drops and you’re good.

But just having a good product won’t cut it in this industry…

With cannabis, traditional advertising isn’t an option.

You can’t be running ads during the Super Bowl or your favorite prime-time sitcom.

So you have to be pretty smart marketers to build your brand.

star divider

This company’s secret weapon is their team.

star divider

They’ve recruited top executives from Philip Morris, Coca-Cola, Kraft Foods, and Eli Lilly.

All major brand builders from the tobacco, beverage, packaged goods, and pharmaceutical industries.

And these guys developed a workaround to the advertising problem.

They launched a separate line of nutritional supplements.

No cannabis in them whatsoever.

They can advertise and sell them anywhere.

This is a really unique idea.

It’s estimated that 60% of cannabis users also take natural health supplements.

So their plan is to build name recognition in that industry.

And that will carry over to their cannabis business.

I think their plan is working out really well so far.

Over the last two years, their sales have multiplied 19X.

To this point, only a couple of cannabis companies have established any brand traction.

Take Cannabis Sativa. 

You could argue they’ve made progress creating brand recognition for their line of beauty products.

C_47

Shareholders have seen their holdings rise as much as 3,165% over the last two years from that.

SPEAKER JOHN BOEHNER:

Canopy Growth has some promising brands under their control now.

They used their financial muscle to buy them, versus build them.

For instance, they just paid $350 million to lock up one of the fastest-growing brands – Tokyo Smoke.

DANNY BRODY:

Canopy’s brand strategy played a huge part in their stock rising 3,813%.

MIKE WARD:

In fact, I’m glad you mentioned Tokyo Smoke.

In 2016, they were a startup that was valued at barely $3 million.

But in 2018, they were a part of a $350 million acquisition.

If you were an angel investor in Tokyo Smoke in 2016, you were very happy when Canopy bought them two years later.

One of the most exciting aspects of the National Institute for Cannabis Investors is that we’re going to show people how they can become angel investors in this industry.

That’s what our fourth report is about.

WYG_04

We’re calling it, simply enough…

The #1 Cannabis Startup to Target Today

DANNY BRODY:

In America, Angel Investing used to be something that only the wealthiest 2% could take part in.

But this has been gradually changing over the years.

Back in 2012, there was a provision in the JOBS Act that opened this world up to everyday investors.

Angel investing is highly speculative. But if you can dedicate a small slice of your portfolio to it, you could earn oversized returns.

You want a legendary example, consider Airbnb.

In 2008, they were a small startup that was renting out air mattresses. 

Like most in Silicon Valley, they needed to raise money from angel investors to grow.

They found some that were willing to back them.

Airbnb was worth $1.5 million then.

Today, they’re worth $31 billion.

Airbnb’s valuation has grown, literally, more than 2,000,000% since those lucky angel investors got in.

I’ve got a buddy who is an angel investor and also produces movies. 

He was on set in Philadelphia for one of his sports films.

He’s talking to another producer – former exec for a major online travel company. 

The guy tells him he passed up the chance to invest in Airbnb’s seed round and it haunts him every day.

SPEAKER JOHN BOEHNER:

As it should.

DANNY BRODY:

Airbnb’s story is more the exception than the rule.

A company rising 2 million percent is quite rare.

But let me give you a more realistic scenario.

I’ve helped take two companies public, the most recent being The Green Organic Dutchman.

If you were an investor when we IPO’d, you could have made 231% in a little more than a month.

C_50

Now rewind back about a year and a half when we were still privately held.

star divider

We sold shares to angel investors for 50 cents apiece. If you had gotten in then, you would have seen a 1,556% gain.

star divider

Since IPO’ing, shares of Aurora Cannabis have risen as high as 1,947%.

That’s a big profit.

About 20 times your money.

But the bigger profit was reserved for their angel investors.

C_51

One of their earliest angels was an electrician who had to be talked into backing this little-known, privately-held cannabis startup.

His original investment is now worth tens of millions of dollars.

MIKE WARD:

In this special report, we’re going to show members all of the ins and outs on how to become a successful angel investor in cannabis startups.

We even have the details on a unique opportunity already locked and loaded for them.

These four special reports are just the beginning of what you can expect as a founding member of the National Institute for Cannabis Investors.

Every month, we’re also going to send you a new Cannabis Investment Package.

It gives you all the research and details on another cannabis opportunity that’s just as big.

To get it in your hands as fast as possible, we’ll email you a copy as soon as it’s available.

And for your records, every month we’ll mail you a physical copy of the research we published. 

Our team has built the most comprehensive database of cannabis companies on the planet.

Every publicly traded cannabis company. And the most promising privately held startups.

They’ve all been carefully analyzed. We’ve looked at their financials, their business plan.

We’ve put their executive through a comprehensive vetting process.  

We assign each company a rating.

It’s a 1-5 scale, so it’s simple to understand.

If we’ve rated a company 5, we’re saying we think their stock is headed straight up.

If it’s a 1, we see it as a dud and you don’t want your money anywhere near it.

Then, every month, we'll take all of the top-rated companies and identify the best of the best.

It could be a firm with a new Breakthrough Treatment

GA_31

A New Cannabis Tech play…

C_56-59

An Emerging Billion-Dollar Brand

C_60-63

Maybe a new opportunity related to Angel Investing.

star divider

We’ll lay out all the details and send you everything you need to know in this Investment Package.

star divider

This monthly package will be very thorough.

It contains all of our research and analysis so you can make a wise decision about whether or not you want to invest.

And we’ll give you a streamlined set of instructions for making the investment.

Just follow along, step-by-step.

DANNY BRODY:

Mike, we didn’t talk about the presentations.

Every investment package we send you comes with an interactive video presentation.

WYG_10

The Institute’s head analyst personally walks you step-by-step through every chart, all the financials, and our projections for future returns.

We want you to see these opportunities through our eyes.

So we’re going to show you exactly how we’re assessing them.

MIKE WARD:

That’s right. And we’re going to be by your side the whole time as these investments develop.

The purpose of this Institute is to build a network of like-minded people…

People like John, Danny, our other board members… and also you.

You’re going to be a part of this network.

star divider

We’re going to conquer this hundred billion – maybe trillion-dollar industry together.

star divider

That’s why we created the Cannabis Investors Network.

We’re leveraging our board members’ intelligence gathering – their business connections – and their political connections.

Every time there’s an opportunity to make big money in this industry, you’ll hear about it first, before the rest of the world gets clued in.

SPEAKER JOHN BOEHNER:

That’s why, in addition to the monthly recommendations from the folks at the Institute – you’ll hear from the brightest CEOs and experts from around the industry.

They’ll conduct business pitches, just for our members.

They’ll explain why you should consider investing in their companies.

MIKE WARD:

We’ve lined up 11 of these business pitches for you on day one.

We’re putting Bruce Linton, the CEO of Canopy Growth – the $14 billion company – on the hot seat.

And Loren Padelford, too.

He’s the vice president of retail giant Shopify.

DANNY BRODY:

Shopify is one of those companies that nobody thinks of as being associated with the cannabis industry.

But they are. We use them in Jamaica.

They’re helping cannabis companies like ours build payment solutions that stay compliant with local and national regulations.

It’s one of the reasons their stock has delivered peak gains of 938%.

C_64

I love finding behind the scenes plays like this.

MIKE WARD:

There are a lot more coming.

Again, we have 11 business pitches waiting for you on day one.

And we have even more top CEOs in the Cannabis industry ready for the hot seat...

I’m not allowed to mention names yet.

But we’re going to start announcing them soon in the Cannabis Investors Network.

Now, when you see the opportunities coming your way, you’ll want to discuss them with other members. 

And you can.

The Cannabis Investors Network lets you create your own forums. 

You can talk about the pitches, or the deals outlined in the investment packages…

You can share your biggest wins…

And discuss other exciting new ways to make money from cannabis.

SPEAKER JOHN BOEHNER:

Board members are going to be very active in this network.

Every month, the Institute hosts a live, online Boardroom Meeting.

You can listen in as leaders in this industry exchange business ideas and present new opportunities.

The board will talk about the deals being worked on – political changes taking place – new players entering the market – and big mergers and acquisitions.

And if you have questions, you can submit them live.

The board members will cover as many as they can.

MIKE WARD:

We want you to take advantage of this ability to collaborate.

There’s even a way for you to take it a step further.

With the click of a few buttons, you can start your own local chapter of the Cannabis Investors Network.

So if you live here in the D.C. area, or Dallas, or Memphis, or anywhere in the U.S., you can schedule meet-ups at a nearby restaurants or pub.

The website makes arranging these simple.

All it takes is a couple clicks.

DANNY BRODY:

You’re going to be hearing about a lot of different opportunities. A lot of big opportunities.

So we’re making it simple for you keep on top of everything happening.

We created an easy-to-use portfolio tracker.

It lets you see every position we’ve recommended so far, their current rating, and how well they’re all performing.

You can also import all your traditional investments if you want.

That way you can see your entire portfolio in one place.

Plus, every week, we’re going to send you a progress report.

If there are new developments, mergers or acquisitions…

Anything you need to know, you’ll be kept in the loop.

MIKE WARD:

And every quarter we will mail you a comprehensive “State of the Cannabis Industry” Dossier.

WYG_14

It will have a complete forecast and projections for each segment of the industry.

Now, we could be in some of these investments for weeks, months, even a year or longer.

But eventually, there will come a time to cash out.

When that happens, we’ll email you a real-time profit alert.

It’s a set of simple, step-by-step instructions. Just follow along and collect any profits you’ve earned.

If you want, we’ll even send you a text message when these emails are released.

Considering how fast some of these plays move, that can be critical to your success.

Look at Tilray. Just two months after their IPO in July of 2018, their stock jumped to peak gains of 1,392%.

C_65

And there were clear signs that this was the exit point.

If you’d waited until the next day to sell, you would have missed out on potentially thousands of dollars in profits.

So these text message alerts can be extremely profitable for you.

SPEAKER JOHN BOEHNER:

You know, it can be intimidating to try new things – like investing in the cannabis industry...

When you’re first coming on board, you’ll probably want to get to know the industry.

So I think a really useful part of the website is the training series.

MIKE WARD:

That’s a great point John.

We wanted to make this accessible to everyone.

So our team created a five-part video training series.

We go in depth on each different segment of the industry.

We’ll show you how to break down the market state by state, and country by country.

We have videos covering the types of cannabis products.

You want to know the difference between flower and hash, concentrates and edibles? These videos will fill you in.

We have videos showing you how to analyze a cannabis business plan, and what to look for.

star divider

We even have a training for folks who have never bought a stock in their life.

star divider

We’ll talk about selecting a brokerage account, depositing and withdrawing funds, placing trades, all the basics.

John, Danny, we’re about out of time.

There’s just one more thing I want to talk about before we go.

Every year, we’re going to host the National Institute for Cannabis Investors Retreat.

You and a guest will be able to attend.

You’ll get to meet face-to-face with some of the biggest names in the industry.

This is very important.

This is also a perfect opportunity to network with your fellow members…

SPEAKER JOHN BOEHNER:

Having spent 30 years in D.C., I can tell you that face-to-face networking like that is a critical part of success.

Deals get done behind closed doors.

So being in that room could be a game changer.

MIKE WARD:

This isn’t going to be all work, John.

We’re going to have some fun, too. We’re hosting a cocktail party. We’ll have a champagne toast prepared.

Maybe we’ll get in a round of golf.

John, how many presidents have you golfed with?

SPEAKER JOHN BOEHNER:

The last three. And no, I’m not saying which one has the lower handicap.

MIKE WARD:

Are you going to squeeze a round in at the retreat?

SPEAKER JOHN BOEHNER:

Of course.

I_Membership card

MIKE WARD:

Gentlemen, we’re about to open the doors to new members.

Before we do, I have a gift for each of you.

Founder’s Membership Cards to the National Institute for Cannabis Investors.

And I have one waiting for you as well. 

star divider

You’re invited to become a Founding Member of the National Institute for Cannabis Investors.

star divider

There is a link below this video. 

It will take you to a short membership application form.

It only takes a few moments to fill out and then we’ll rush you your new member package.

In addition to your founder’s membership card, your package includes the four special reports we just talked about.

Then every month you get your new Cannabis Investment Package.

Through the Cannabis Investors Network, you’ll receive virtual pitches from CEOs of the most promising cannabis companies around the industry...

You can submit questions in our monthly boardroom meetings. 

And we’ll be by your side every step of the way with our weekly progress reports and real-time profit alerts.

WYG_20 star divider

We’ve set this Institute up to give you all the information, access and guidance you need to help you make a fortune from cannabis.

star divider

As you can see, we’ve pulled out all the stops.

We’re doing everything we can to help you create the kind of wealth that lasts generations.

We’ve called in every favor we could and spent millions of dollars setting up this Institute…

Which is why it’s not inexpensive to join.

Down the road, we plan to offer regular memberships for $599 a year.

That’s a fair price for everything you’re getting.

However, as a founding member, you won’t pay anywhere near that.

Forget 50%... or 60%... or 70%... or even 80% off...

As a founding member, you get an unbelievable discount…

This is a deal too good to pass up.

You have to click the button below to get the details.

star divider

When you do, you’ll also discover that your membership is protected by not one, but two 100% money-back guarantees. So there’s no risk to you for joining.

star divider

Look, we’ve never seen an opportunity like the one we have today with cannabis.

You have the chance to get into cannabis before the federal government ends the prohibition…

Before big institutions pour billions of dollars into it, which can turn every day Americans into millionaires.

star divider

To be absolutely clear, this is the opportunity of a lifetime. And I don’t want you to miss it.

star divider

So click the button below and complete the brief membership application on the next page.

Speaker John Boehner, Danny Brody, thank you so much for joining us today.

SPEAKER JOHN BOEHNER:

It’s been a pleasure. I can’t wait to meet the new members coming on board.

DANNY BRODY:

Same here. This is going to be a turning point for a lot of people.

MIKE WARD:

And thank you for being such an important part of today’s event.

We look forward to seeing you as a founding member of the National Institute for Cannabis Investors.

JOIN NOW

PS: If you have any questions about the National Institute for Cannabis Investors and how it will work for you, I encourage you to contact our reliable customer service team at 866.260.0361 or 410.777.8270 (international) and mention Priority Code: WCIRV7AK.

star divider